Search results
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 4 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 7 days agoNovavax (NVAX -9.65%) and Moderna (MRNA 0.17%) both entered the coronavirus vaccine race around the...
Could Novavax Become the Next Moderna?
The Motley Fool via AOL· 7 days agoNovavax's $1.2 billion deal Last week, Novavax announced a $1.2 billion partnership with Sanofi. The pharmaceutical giant will pay Novavax</ ...
COVID’s New ‘FLiRT’ Variants—What To Know As Experts Fear Summer Surge
Forbes· 2 days agoNew coronavirus variants dubbed “FLiRT” are circulating the world and growing dominant in the U.S.,...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 1 day agoOther vaccine stocks are climbing as well. Shares of CureVac which, like Moderna, develops messenger...
Novavax Sees Unusually Large Options Volume (NASDAQ:NVAX)
ETF DAILY NEWS· 1 day agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Novavax has a 1 year low of $3.53 and ...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 16 hours agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 2 days ago“We don’t yet know if the manufacturers will have patient assistance programs.” Vaccine...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks· 1 day agoFree Report) and Pfizer (PFE Quick QuotePFE - Free Report) to set up a possible vaccine program aimed at preventing the spread of the H5N1 virus, also known as bird flu, in ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 5 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...